Vistin Pharma ASA (DE:VP4)
FRANKFURT:VP4
Want to see DE:VP4 full AI Analyst Report?
VP4 Stock Chart & Stats
€1.83
-€0.02(-0.75%)
At close: 4:00 PM EST
€1.83
-€0.02(-0.75%)
Day’s Range― - ―
52-Week Range€1.66 - €2.28
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€90.47M
Enterprise Value€1.03B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)13.6
Beta0.32
Next Earnings
Apr 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding44,344,593
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vistin Pharma ASA News
VP4 FAQ
What was Vistin Pharma ASA’s price range in the past 12 months?
Vistin Pharma ASA lowest stock price was €1.66 and its highest was €2.28 in the past 12 months.
What is Vistin Pharma ASA’s market cap?
Vistin Pharma ASA’s market cap is €90.47M.
When is Vistin Pharma ASA’s upcoming earnings report date?
Vistin Pharma ASA’s upcoming earnings report date is Apr 24, 2026 which is in 6 days.
How were Vistin Pharma ASA’s earnings last quarter?
Vistin Pharma ASA released its earnings results on Feb 12, 2026. The company reported €0.033 earnings per share for the quarter, beating the consensus estimate of N/A by €0.033.
Is Vistin Pharma ASA overvalued?
According to Wall Street analysts Vistin Pharma ASA’s price is currently Overvalued.
Does Vistin Pharma ASA pay dividends?
Vistin Pharma ASA does not currently pay dividends.
What is Vistin Pharma ASA’s EPS estimate?
Vistin Pharma ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vistin Pharma ASA have?
Vistin Pharma ASA has 44,344,593 shares outstanding.
What happened to Vistin Pharma ASA’s price movement after its last earnings report?
Vistin Pharma ASA reported an EPS of €0.033 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.387%.
Which hedge fund is a major shareholder of Vistin Pharma ASA?
Currently, no hedge funds are holding shares in DE:VP4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vistin Pharma ASA
Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.